Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Classement en actions #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Prix de l'action
$62.83
Capitalisation boursière
$93.23B
Changement (1 jour)
-9.17%
Changement (1 an)
-31.36%
Pays
US
Échange Boston Scientific Corporation (BSX)

Catégorie

Bénéfices pour Boston Scientific Corporation (BSX)
Bénéfices en Dec 2025 TTM : $3.39B
Selon les derniers rapports financiers de Boston Scientific Corporation, les bénéfices actuels de l'entreprise sont de $3.39B. En 2024, l'entreprise a réalisé un bénéfice de $2.28B, une augmentation par rapport à celui de 2023 qui était de $1.99B. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Boston Scientific Corporation de 2000 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $3.39B 0.00%
2025 $3.39B 48.33%
2024 $2.28B 14.96%
2023 $1.99B 73.97%
2022 $1.14B 6.04%
2021 $1.08B -1,462.03%
2020 $-79.00M -111.50%
2019 $687.00M -51.69%
2018 $1.42B 52.41%
2017 $933.00M 427.12%
2016 $177.00M -127.23%
2015 $-650.00M 27.70%
2014 $-509.00M 128.25%
2013 $-223.00M -94.57%
2012 $-4.11B -739.72%
2011 $642.00M -160.40%
2010 $-1.06B -18.73%
2009 $-1.31B -35.60%
2008 $-2.03B 256.94%
2007 $-569.00M -83.90%
2006 $-3.54B -496.75%
2005 $891.00M -40.36%
2004 $1.49B 132.35%
2003 $643.00M 17.12%
2002 $549.00M 1,147.73%
2001 $44.00M -91.65%
2000 $527.00M 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$8.47B 150.10%
US
$4.51B 33.35%
US
$5.56B 64.38%
IE
$5.56B 64.34%
IE
$3.13B -7.48%
DE